Invesco Ltd. Organogenesis Holdings Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Invesco Ltd. holds 148,697 shares of ORGO stock, worth $673,597. This represents 0.0% of its overall portfolio holdings.

Number of Shares

148,697

Previous 1,069,252 86.09%

Holding current value

$673,597

Previous $4.62 Million 88.22%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$2.66 - $5.34 $2.45 Million - $4.92 Million	-920,555 Reduced 86.09%	148,697 $544,000
Q1 2025 May 12, 2025	BUY	$2.89 - $6.21 $2.74 Million - $5.89 Million	947,705 Added 779.7%	1,069,252 $4.62 Million
Q4 2024 Feb 13, 2025	BUY	$2.77 - $4.43 $5,121 - $8,191	1,849 Added 1.54%	121,547 $388,000
Q3 2024 Nov 12, 2024	SELL	$2.42 - $3.24 $356,826 - $477,734	-147,449 Reduced 55.19%	119,698 $342,000
Q2 2024 Aug 13, 2024	BUY	$2.28 - $3.03 $99,863 - $132,714	43,800 Added 19.61%	267,147 $748,000
Q1 2024 May 14, 2024	BUY	$2.61 - $4.49 $518,043 - $891,193	198,484 Added 798.31%	223,347 $634,000
Q4 2023 Feb 12, 2024	BUY	$1.97 - $4.21 $5,498 - $11,750	2,791 Added 12.64%	24,863 $101,000
Q3 2023 Nov 13, 2023	BUY	$2.34 - $4.43 $5,349 - $10,126	2,286 Added 11.55%	22,072 $70,000
Q2 2023 Aug 11, 2023	SELL	$1.9 - $4.3 $16,174 - $36,605	-8,513 Reduced 30.08%	19,786 $65,000
Q1 2023 May 12, 2023	SELL	$1.89 - $2.93 $1.63 Million - $2.52 Million	-861,453 Reduced 96.82%	28,299 $60,000
Q4 2022 Feb 13, 2023	BUY	$2.48 - $3.43 $731,798 - $1.01 Million	295,080 Added 49.62%	889,752 $2.39 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $212,951 - $436,076	67,819 Added 12.87%	594,672 $1.93 Million
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $71,493 - $122,926	15,083 Added 2.95%	526,853 $2.57 Million
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $357,558 - $528,876	-55,264 Reduced 9.75%	511,770 $3.9 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $1.81 Million - $2.7 Million	200,293 Added 54.61%	567,034 $5.24 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $1.26 Million - $1.58 Million	91,711 Added 33.35%	366,741 $5.22 Million
Q2 2021 Aug 17, 2021	SELL	$14.92 - $23.23 $2.44 Million - $3.8 Million	-163,382 Reduced 37.27%	275,030 $4.57 Million
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $3.13 Million - $8.99 Million	427,096 Added 3774.27%	438,412 $7.99 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $41,077 - $85,209	11,316 New	11,316 $85,000

Others Institutions Holding ORGO

# of Institutions

122

Shares Held

69.9M

Call Options Held

15.1K

Put Options Held

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $593M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account